The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sarepta Therapeutics (NASDAQ:SRPT) 
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscul...
Website: http://www.sarepta.com
Founded: 1980
Full Time Employees: 743
Sector: Healthcare
Industry: Biotechnology
Sarepta Therapeutics Days Payable Outstanding ttm (DPO)
Sarepta Therapeutics Days Receivable Outstanding ttm (DSO)
Sarepta Therapeutics Days Inventory Outstanding ttm (DIO)
Sarepta Therapeutics Op Cashflow Per Share ttm
Sarepta Therapeutics Free Cashflow Per Share ttm
Sarepta Therapeutics Cash Per Share ttm
Sarepta Therapeutics P/S ratio ttm
Sarepta Therapeutics (GAAP) P/E ratio ttm
Sarepta Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.